XML 62 R46.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value of Financial Assets and Liabilities - Additional Information (Detail) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Transfers between fair value levels $ 0  
Measurement Input, Expected Dividend Rate [Member]    
Expected dividend yield 0.00%  
Genzyme Agreement [Member]    
Fair value of derivative liability $ 0 $ 183,000
Arsanis [Member] | Genzyme Agreement [Member]    
Fair value of derivative liability $ 0  
Series A Convertible Preferred Stock [Member] | Arsanis And Merger Sub [Member]    
Preferred stock Fair value per share   $ 1.70
Series B Convertible Preferred Stock [Member] | Arsanis And Merger Sub [Member]    
Preferred stock Fair value per share   $ 1.86
Convertible Preferred Stock [Member]    
Number of warrants for purchase of convertible preferred shares 0